The exchange centers on a deep learning model developed by a team led by Yohei Sanmoto and Kouji Masumoto of University of Tsukuba Hospital, together with collaborators at what is now the Institute of Science Tokyo. Their original study, published in early October 2026, described the development and evaluation of a computer-aided diagnosis model designed to detect neonatal pneumothorax on chest radiographs. Shortly afterward, another group responded with a commentary that posed a deceptively simple question: beyond overall accuracy, does an artificial intelligence model detect the neonatal pneumothoraces that matter most? The Tsukuba-led team has now published a formal reply, and the resulting dialogue, classified by the journal as a Matters Arising piece, exposes a fault line that runs through much of medical AI research: the gap between statistical performance measured on a dataset and clinical usefulness measured at the bedside.

The core of the critique is a familiar one to anyone who follows diagnostic algorithms. Overall accuracy, sensitivity, and area under the receiver operating characteristic curve are aggregate statistics. They treat every positive case as equivalent, every false negative as equally costly, and every false positive as equally benign. Clinical reality is not so symmetrical. A small, asymptomatic pneumothorax in a breathing, stable infant may be appropriately observed, while a tension pneumothorax in a ventilated preterm neonate demands immediate needle decompression. A model that reliably catches the catastrophic cases but occasionally misses the subtle ones may be far more valuable in practice than a model with a marginally higher overall accuracy that fails precisely when failure is unacceptable. The commentary’s authors evidently argued that the evaluation of the deep learning model should have been stratified by clinical severity or relevance, not reported only in aggregate.

The reply from Sanmoto, Gao, Hitaka, Zhu, and Masumoto engages with that argument directly, defending the design choices of their original study while acknowledging the legitimacy of the underlying concern. Although the full text of the reply is available to subscribers, the structure of the exchange is itself instructive. The responding authors pressed on whether the model’s reported performance translates into detection of clinically significant pneumothoraces, and the original team responded by situating their work within the constraints and realities of neonatal datasets. Building any AI system for a rare, acute condition in a fragile population means working with limited case numbers, imperfect reference standards, and ground truth labels that are themselves derived from radiologist interpretation, the very process the algorithm is meant to support or augment.

That last point deserves emphasis, because it illustrates why neonatal pneumothorax detection is such a demanding test case for medical AI. Supervised deep learning requires annotated examples, and in radiology those annotations typically come from expert readers. But expert readers disagree, particularly on borderline findings in difficult populations. Inter-reader variability in neonatal chest radiograph interpretation is well documented, which means the labels used to train and validate a model carry their own uncertainty. When a commentary asks whether a model detects the pneumothoraces that matter most, part of the honest answer is that defining what matters most, and establishing it reliably in a reference dataset, is itself an unresolved methodological challenge. Severity grading, symptom correlation, and downstream intervention all matter, yet retrospective image archives rarely capture them consistently.

The clinical stakes of the debate are grounded in real evidence about how pneumothorax is managed in newborns. A randomized clinical trial published in JAMA Pediatrics in 2018 by Murphy and colleagues across several European neonatal centers examined whether needle aspiration of pneumothorax reduced subsequent chest drain insertion in newborns, reflecting an ongoing effort to define which infants truly need invasive intervention and which can be managed conservatively. That trial, and the broader literature it belongs to, underscores that not all detected pneumothoraces lead to the same clinical action. An AI system that flags every radiographic air collection with equal alarm could, paradoxically, increase unnecessary procedures in a population where minimizing invasive interventions is a explicit therapeutic goal. Conversely, a system tuned too conservatively could delay detection of the tension pneumothorax that kills. Calibration of alerts to clinical context is not a luxury; it is the entire point.

Evidence from other domains of chest imaging suggests that AI assistance can deliver its greatest benefit to the clinicians least trained in image interpretation. A 2024 study in the journal Chest by Rudolph and colleagues found that non-radiology health care professionals benefited significantly from AI assistance in interpreting emergency-related chest radiographs, while a separate two-center evaluation published in European Radiology by Topff and colleagues showed that AI-assisted double reading of chest radiographs could help detect clinically relevant missed findings. In the neonatal unit, where films are often first seen by pediatricians, neonatologists, or trainees rather than subspecialty pediatric radiologists, the analogous hope is that a well-calibrated algorithm functions as a safety net, catching the critical finding that a fatigued clinician overlooked at three in the morning. But that safety-net function depends entirely on how the model’s errors are distributed, which is exactly the question raised in this exchange.

The Matters Arising format itself is worth noting as a feature of a healthy scientific ecosystem. Rather than allowing disagreements about evaluation methodology to dissipate into citation counts or conference talks, Pediatric Radiology has provided a venue for a direct, structured rebuttal and response, with both the commentary and the reply published in quick succession in October 2026. The timeline recorded in the journal’s records shows the reply was received on 21 September 2026, revised on 29 September, accepted on 2 October, and published on 14 October, a turnaround measured in weeks. For a field in which algorithms are being marketed toward clinical deployment faster than independent validation can proceed, this kind of rapid, public methodological scrutiny is one of the few reliable quality-control mechanisms available.

What emerges from the exchange is less a verdict on one model than a template for how AI diagnostic tools for rare, time-critical conditions should be judged. The Tsukuba team’s reply, drafted by Sanmoto and critically revised by all co-authors, signals a willingness to defend their work in public while the deeper questions remain open: how to stratify performance by clinical severity, how to assemble validation cohorts large enough to support such stratification for a condition that is uncommon even in high-volume neonatal centers, and how to set operating thresholds that reflect the asymmetric costs of missing a tension pneumothorax versus over-calling a benign one. The authors disclosed no conflicts of interest and noted that they used a commercial language model only for editorial refinement of their manuscript, with full responsibility retained by the human authors, a transparency practice increasingly expected in this literature.

For clinicians and hospital technology committees watching the medical AI landscape, the lesson of this exchange is to ask the second-order question whenever a vendor or a paper reports impressive headline accuracy. Accuracy on which cases? Missed at what clinical cost? Validated against what reference standard, and in which patient population? In neonatal pneumothorax detection, where the target condition is rare, the patients are fragile, and the window for intervention is measured in minutes, those questions are not academic pedantry. They are the difference between an algorithm that genuinely protects newborns and one that merely performs well on a spreadsheet. The debate between the commentary authors and the model developers has not settled the matter, but by forcing the distinction between statistical and clinical performance into the open, it has made the path forward clearer for every research group building detection systems for the sickest and smallest patients.

Subject of Research: Evaluation of a deep learning model for detecting clinically significant neonatal pneumothorax on chest radiographs

Article Title: Response to: Beyond overall accuracy: does an artificial intelligence model detect the neonatal pneumothoraces that matter most? Reply to Sanmoto et al.

Article References: Response to: Beyond overall accuracy: does an artificial intelligence model detect the neonatal pneumothoraces that matter most? Reply to Sanmoto et al.. (n.d.). https://doi.org/10.1007/s00247-026-06804-x

Image Credits: AI Generated

DOI: 10.1007/s00247-026-06804-x

Keywords: artificial intelligence, deep learning, neonatal pneumothorax, chest radiography, pediatric radiology, computer-aided diagnosis, neonatology, diagnostic accuracy, clinical validation, matters arising, predictive medicine, machine learning

The exchange centers on a study by Sanmoto and colleagues, published in the same journal on 12 September 2026, in which the researchers developed and evaluated a deep learning model for computer-aided diagnosis of neonatal pneumothorax on chest radiographs. Deep learning models of this kind are trained on large sets of labeled X-ray images, learning to recognize the visual signatures of air collecting in the pleural space around a lung. In adults, such tools have advanced rapidly, but the newborn chest presents a far harder problem: small lungs, thymic shadows, respiratory support devices, skin folds and atelectasis all conspire to create images where air collections and normal structures can be genuinely difficult to tell apart, even for experienced readers.

The Turkish authors’ reply, published on 8 October 2026, does not dispute the technical achievement of building such a model. Their concern is conceptual and clinical. A pneumothorax in a newborn is not a binary event with uniform consequences. Some air leaks are small, asymptomatic and resolve on their own under observation. Others are tension pneumothoraces, in which accumulating air shifts the mediastinum, compresses the contralateral lung, impairs venous return and threatens cardiovascular collapse within minutes. A detection system that performs well on the average case but stumbles on the tension physiology that demands immediate needle decompression would score respectably on paper while failing precisely where it matters most.

This is why the correspondence invokes the question in its title: does the model detect the neonatal pneumothoraces that matter most? Overall accuracy, the authors argue, blends together easy and hard cases, clinically trivial and clinically urgent findings, into a single figure that can mask systematic blind spots. In a dataset where small pneumothoraces outnumber large ones, a model could achieve high accuracy while missing a disproportionate share of the large, dangerous leaks. Conversely, sensitivity reported across all pneumothoraces tells clinicians nothing about sensitivity restricted to the subset requiring intervention. The metrics that matter for deployment are stratified ones, broken down by size, laterality, tension features and the patient’s clinical status.

The reply grounds this argument in the evolving evidence on how neonatal pneumothorax should be managed. Tatar and colleagues cite work by Baillie and colleagues, published in 2026 in the journal Children, which explored whether simple radiographic measurements can predict the need for intervention in neonatal pneumothorax. That line of research reflects a broader shift in neonatology toward tailoring treatment to severity rather than treating every radiographically visible air leak identically. If radiologists and neonatologists increasingly use measurements on the film to decide who needs a chest drain and who can be watched, then an AI system intended to support those decisions must be evaluated against the same clinically meaningful thresholds, not against a generic label of pneumothorax present or absent.

Management evidence reinforces the stakes. The authors also point to a randomized clinical trial by Murphy and colleagues, published in JAMA Pediatrics in 2018, which examined the effect of needle aspiration of pneumothorax on subsequent chest drain insertion in newborns. That trial is part of the movement toward less invasive first-line treatment for symptomatic air leaks in neonates, an approach that reduces drain placement in many infants. But selective, less invasive management depends entirely on accurate, timely characterization of the leak. If the imaging assessment that feeds into those decisions is delegated partly to an algorithm, the algorithm’s errors propagate directly into triage: a missed significant pneumothorax delays decompression, while a false alarm on an incidental small leak can trigger an unnecessary invasive procedure in a fragile premature infant.

The technical implications for model development are substantial. Training and validating a neonatal pneumothorax detector on binary labels alone invites the very failure mode the correspondence describes. A more clinically attuned pipeline would annotate lesions by size and tension features, weight the loss function toward the high-severity cases, and report performance separately for clinically significant versus clinically insignificant pneumothoraces. External validation on datasets from different scanners, different patient populations and different levels of prematurity would test whether the model generalizes beyond its development environment. Calibration, too, deserves attention: a model that outputs a probability should have that probability mean what it claims, because downstream triage thresholds are only meaningful if the underlying scores are trustworthy.

None of these caveats diminish the promise of computer-aided diagnosis in the neonatal intensive care unit. Chest radiography remains the first-line imaging modality for suspected air leak in newborns, and interpretation is subject to interobserver variability, fatigue and the time pressures of a busy unit. A well-validated AI system could serve as a second reader, flagging studies that need urgent review and reducing the chance that a tension pneumothorax sits unnoticed while a radiologist works through a queue. The point raised by Tatar, Yılmaz and Köker Özer is that realizing this promise requires evaluation frameworks aligned with clinical reality, not just with classification benchmarks. The reply, notably, was prepared with the assistance of ChatGPT for language refinement and editorial organization, with the authors critically reviewing the output and taking full responsibility for the content, an example of the transparency about AI use that journals increasingly expect.

The exchange also illustrates the healthy function of the Matters Arising format itself. Rather than letting an optimistic headline metric stand unchallenged, the correspondence process allows the community to interrogate what a result actually demonstrates and what it does not. Sanmoto and colleagues’ model represents a genuine step toward computer-aided diagnosis of neonatal pneumothorax, and the reply does not assert that the model fails; it insists that the evidence presented does not yet answer the question of whether the pneumothoraces that matter most are being caught. That distinction between not proven and disproven is exactly the kind of nuance that rigorous scientific debate is designed to surface, and it is a nuance that single-number summaries in press releases and abstracts tend to erase.

For clinicians, developers and regulators watching AI enter pediatric imaging, the lesson of this exchange is portable well beyond one model and one disease. Every deployment of diagnostic AI should begin by asking which errors are acceptable and which are catastrophic, and then demand performance data stratified accordingly. In neonatal pneumothorax, the catastrophic error is missing the large or tension leak in a newborn already struggling to breathe; the acceptable one may be a borderline call on a tiny asymptomatic collection that a clinician would watch anyway. Accuracy statistics that do not separate these scenarios are, as the Inonu University authors make clear, answering a question nobody in the intensive care unit is asking. The next generation of validation studies, evaluated against intervention thresholds and severity strata, will determine whether deep learning can truly earn a place beside the neonatal radiologist, and whether its confidence can be trusted when a newborn’s collapsed lung is quietly becoming an emergency.

Subject of Research: Evaluation of deep learning models for detecting clinically significant neonatal pneumothorax on chest radiographs

Article Title: Beyond overall accuracy: Does an artificial intelligence model detect the neonatal pneumothoraces that matter most? Reply to Sanmoto et al.

Article References: Tatar, D., Yılmaz, E., & Köker Özer, N. (2026). Beyond overall accuracy: Does an artificial intelligence model detect the neonatal pneumothoraces that matter most? Reply to Sanmoto et al.. Pediatric Radiology. https://doi.org/10.1007/s00247-026-06805-w

Image Credits: AI Generated

DOI: 10.1007/s00247-026-06805-w

Keywords: artificial intelligence, deep learning, neonatal pneumothorax, pediatric radiology, chest radiography, computer-aided diagnosis, neonatology, model validation, tension pneumothorax, clinical significance, chest drain, matters arising

Neonatal pneumothorax is a deceptively difficult diagnostic target. It occurs in roughly 0.05 to 2 percent of all newborns and in as many as 9.2 percent of very preterm infants who require respiratory support. While many cases resolve on their own, others deteriorate rapidly into hypoxemia or hemodynamic instability demanding urgent intervention. The standard screening tool, a supine anteroposterior chest X-ray, is far from perfect. A recent meta-analysis reported pooled sensitivity of 82 percent and specificity of 96 percent for physician-interpreted supine neonatal chest radiography. The fundamental problem is geometric: when a baby lies on its back, free air collects anteriorly or medially in the chest rather than at the lung apex, exactly where radiologists are trained to look in upright adults. Combine that with a tiny thoracic volume, mediastinal overlap, poor inspiration, and often coexisting lung disease, and even skilled readers can overlook a clinically significant air leak.

Existing artificial intelligence tools do not simply transfer to this population. When software approved for adults was applied to pediatric chest radiographs, diagnostic performance varied sharply by age, and children aged two years or younger accounted for 81.5 percent of the incorrect predictions. That sobering statistic motivated the research team to build a model designed specifically for the youngest patients. Their approach relied on a ResNet-18 convolutional neural network, initialized with ImageNet weights and then further pre-trained in a self-supervised manner on 1,802 publicly available normal adult chest radiographs, allowing the encoder to learn general radiographic features such as lung-field structure, rib and soft-tissue contrast, and texture before ever encountering a neonatal image.

The training pipeline was architecturally sophisticated. After self-supervised pre-training, the researchers fine-tuned a teacher model on neonatal radiographs, then trained a student model of identical architecture using knowledge distillation, a technique in which the student learns not only from hard binary labels but also from the softened probability distributions produced by the teacher. The team reports that the full configuration, combining adult-chest pre-training with distillation, outperformed both plain ImageNet initialization and adult pre-training without distillation on the test set. Each radiograph was preprocessed into a three-channel image containing original, lighter, and darker versions, a clever trick to simulate the brightness variability of real bedside imaging and force the model to learn exposure-insensitive features.

The dataset itself was formidable. Drawing on fourteen years of records, from January 2011 to December 2024, at a single tertiary university hospital, the researchers assembled 648 pneumothorax radiographs from 288 neonates and 5,511 control radiographs from 3,377 neonates who never developed the condition. A pediatric surgeon and a neonatologist, each with more than a decade of clinical experience, jointly reviewed every image to establish reference labels, recording laterality and anatomical distribution of the air collections. Data were split at the patient level into training, validation, and test sets in a 7:1:2 ratio, ensuring that no infant’s images leaked across partitions. An eight-fold cross-validation procedure then fixed the decision threshold at 0.06, selected to maximize specificity while keeping sensitivity at or above 90 percent, a prespecified constraint reflecting the model’s intended role as a screening and decision-support tool where missed cases are the costliest errors.

On the held-out test set of 1,231 images, the model delivered an AUC of 0.975, with sensitivity of 87.6 percent, specificity of 95.3 percent, accuracy of 94.5 percent, and a negative predictive value of 98.5 percent, meaning a negative result was highly trustworthy. Patient-level analyses, whether using the earliest radiograph per neonate or averaging probabilities across all of a baby’s films, yielded nearly identical AUCs of 0.976 and 0.977. The Brier score of 0.0309 indicated reasonable calibration, although the calibration curve showed some deviation in the intermediate and high probability ranges where few observations existed. The positive predictive value of 68.5 percent, however, means roughly one in three positive alerts was a false positive, which the authors caution could burden clinicians with unnecessary urgent reviews if the model were deployed naively as a standalone rule-in test.

Interpretability analysis added an intriguing wrinkle. Using gradient-weighted class activation mapping, or Grad-CAM, the team examined whether the model’s visual attention landed on the correct lung. Among 163 lung-level evaluations, activation matched the clinically determined side in 91.3 percent of right-lung instances but only 67.6 percent of left-lung instances, a statistically significant disparity. The researchers attribute this asymmetry partly to the greater radiographic complexity of the left hemithorax, where overlap from the cardiac silhouette and mediastinal structures obscures pleural air, and partly to dataset imbalance: right-sided pneumothoraces appeared in 80.7 percent of the positive films versus 64.8 percent for the left side, leaving the model with fewer examples of left-sided patterns, particularly lateral lesions, to learn from.

Perhaps the most clinically revealing finding came from logistic regression of misclassification factors. Transient tachypnea of the newborn, a common condition marked by perihilar congestion and delayed clearance of fetal lung fluid, was independently associated with model error, with an odds ratio of 1.88, while gestational age also contributed modestly with an odds ratio of 1.10 per week. Transient tachypnea appeared in 32.7 percent of false positives and fully half of all false negatives. The interpretation is that deep networks read the whole image rather than isolated signs, so background pulmonary abnormalities can either mimic pneumothorax patterns or camouflage true ones. The model, in other words, is sensitive not just to the pathology itself but to the radiographic context in which it sits, a lesson likely to generalize across pediatric AI systems.

The authors are careful about scope. The study is retrospective and single-center, the reference standard rested on consensus radiograph review rather than ultrasound or CT confirmation, no pediatric radiologist participated in annotation, and no direct comparison with physician readers was performed. External and prospective validation is explicitly warranted before any clinical implementation. Yet the trajectory is clear and exciting. The performance achieved here is comparable to or better than adult pneumothorax AI models, which typically report AUCs between 0.87 and 0.98, and it slightly exceeds NeoCLIP, a recent self-supervised neonatal foundation model that achieved an AUC of 0.93 for pneumothorax across multiple findings. Positioned as a screening adjunct rather than an autonomous diagnostician, with positive outputs always paired with clinical judgment, this neonate-specific model suggests that age-tailored AI can finally give the smallest and most vulnerable patients the diagnostic safety net their adult counterparts have begun to enjoy.

Subject of Research: Development of a deep learning model for detecting pneumothorax on supine chest radiographs of newborns

Article Title: Development and evaluation of a deep learning model for computer-aided diagnosis of neonatal pneumothorax on chest radiographs

Article References: Sanmoto, Y., Gao, Q., Hitaka, D., Zhu, X., & Masumoto, K. (2026). Development and evaluation of a deep learning model for computer-aided diagnosis of neonatal pneumothorax on chest radiographs. Pediatric Radiology. https://doi.org/10.1007/s00247-026-06778-w

Image Credits: AI Generated

DOI: 10.1007/s00247-026-06778-w

Keywords: artificial intelligence, deep learning, neonatal pneumothorax, chest radiography, neonatology, ResNet-18, knowledge distillation, Grad-CAM, computer-aided diagnosis, pediatric radiology, transient tachypnea of the newborn, NICU